SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022915
Filing Date
2022-08-15
Accepted
2022-08-15 16:43:32
Documents
55
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1167292
2 ex31-1.htm EX-31.1 10963
3 ex31-2.htm EX-31.2 10944
4 ex32-1.htm EX-32.1 4391
5 ex32-2.htm EX-32.2 7230
  Complete submission text file 0001493152-22-022915.txt   4565878

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgs-20220630.xsd EX-101.SCH 38912
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT orgs-20220630_cal.xml EX-101.CAL 58253
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT orgs-20220630_def.xml EX-101.DEF 133045
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgs-20220630_lab.xml EX-101.LAB 308235
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgs-20220630_pre.xml EX-101.PRE 229181
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 597087
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38416 | Film No.: 221166268
SIC: 2834 Pharmaceutical Preparations